These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [European drug market--dream or nightmare?]. Nord Med; 1974 Jan; 89(1):6-8. PubMed ID: 4819431 [No Abstract] [Full Text] [Related]
3. [Drug problems and the Common Market. Personal views]. Andersen AH Ugeskr Laeger; 1973 Jun; 135(25):1300-1. PubMed ID: 4800706 [No Abstract] [Full Text] [Related]
4. [Detection of side effects. 2: Responsibilities of the pharmaceutical industry, drug commissions, the Federal Health Office and international organizations]. Gleiter CH; Bieck PR Fortschr Med; 1991 Jul; 109(21):429-31. PubMed ID: 1916572 [No Abstract] [Full Text] [Related]
5. Remarks at the Food and Drug Law Institute's 48th Annual Conference. Niedelman SM Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089 [No Abstract] [Full Text] [Related]
6. [Nordic cooperation on drug control, registration, information. A Gordian knot?]. Naess K Nord Med; 1974 Jan; 89(1):1-2. PubMed ID: 4819426 [No Abstract] [Full Text] [Related]
7. [Letter: International cooperation in drugs must be a simplification, not a complication]. Thrane O Nord Med; 1974 Feb; 89(2):35-6. PubMed ID: 4820743 [No Abstract] [Full Text] [Related]
8. [European Council: new legal dispositions on drugs and drug traffickers]. CICIAMS Nouv; 1973; (3):28-32. PubMed ID: 4491675 [No Abstract] [Full Text] [Related]
9. [Possibilities and limits of drug supervision]. Homann G Med Klin; 1970 Aug; 65(35):1518-20. PubMed ID: 5516116 [No Abstract] [Full Text] [Related]
10. [The EEC creates a European Medical Product Agency]. Johnson K Lakartidningen; 1993 Oct; 90(40):3395. PubMed ID: 8231477 [No Abstract] [Full Text] [Related]
11. The shape of European business in 2003. Wagner M Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520 [No Abstract] [Full Text] [Related]
12. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances. Joranson DE NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529 [No Abstract] [Full Text] [Related]
13. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem. Teufel AT J Contemp Health Law Policy; 2006; 22(2):383-408. PubMed ID: 17117702 [No Abstract] [Full Text] [Related]
14. [Europe 1993 and drugs]. Reuse J Bull Mem Acad R Med Belg; 1990; 145(8-9):341-9; discussion 349-50. PubMed ID: 2099233 [No Abstract] [Full Text] [Related]
15. Panel discussion: problems arising from differences in domestic and international regulations. Bull Parenter Drug Assoc; 1973; 27(3):126-38. PubMed ID: 4709160 [No Abstract] [Full Text] [Related]
16. The International Conference on Harmonization common technical document--global submission format? Molzon JA Food Drug Law J; 2005; 60(3):447-51. PubMed ID: 16304749 [No Abstract] [Full Text] [Related]
17. [Procedure and documentation of quality control]. Cavatorta L; Vianello S Boll Chim Farm; 1970 Aug; 109(8):463-6. PubMed ID: 5502286 [No Abstract] [Full Text] [Related]
19. The international (mainly European) attitude to the drug driving problem--legislation and countermeasures. Irving A Int Clin Psychopharmacol; 1988 May; 3 Suppl 1():13-21. PubMed ID: 3403945 [No Abstract] [Full Text] [Related]
20. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering? Purnhagen KP Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663 [No Abstract] [Full Text] [Related] [Next] [New Search]